Literature DB >> 12576135

Regulation of cardiac myocyte cell death.

Angela Clerk1, Sharon M Cole, Timothy E Cullingford, Joanne G Harrison, Mika Jormakka, Donna M Valks.   

Abstract

Cardiac myocyte death, whether through necrotic or apoptotic mechanisms, is a contributing factor to many cardiac pathologies. Although necrosis and apoptosis are the widely accepted forms of cell death, they may utilize the same cell death machinery. The environment within the cell probably dictates the final outcome, producing a spectrum of response between the two extremes. This review examines the probable mechanisms involved in myocyte death. Caspases, the generally accepted executioners of apoptosis, are significant in executing cardiac myocyte death, but other proteases (e.g., calpains, cathepsins) also promote cell death, and these are discussed. The two principal cell death pathways (death receptor- and mitochondrial-mediated) are described in relation to the emerging structural information for the principal proteins, and they are discussed relative to current understanding of myocyte cell death mechanisms. Whereas the mitochondrial pathway is probably a significant factor in myocyte death in both acute and chronic phases of myocardial diseases, the death receptor pathway may prove significant in the longer term. The Bcl-2 family of proteins are key regulators of the mitochondrial death pathway. These proteins are described and their possible functions are discussed. The commitment to cell death is also influenced by protein kinase cascades that are activated in the cell. Whereas certain pathways are cytoprotective (e.g., phosphatidylinositol 3'-kinase), the roles of other kinases are less clear. Since myocyte death is implicated in a number of cardiac pathologies, attenuation of the death pathways may prove important in ameliorating such disease states, and possible therapeutic strategies are explored.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576135     DOI: 10.1016/s0163-7258(02)00339-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  20 in total

1.  Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction.

Authors:  Jianquan Liao; Aijun Sun; Yeqing Xie; Toyoshi Isse; Toshihiro Kawamoto; Yunzeng Zou; Junbo Ge
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

2.  Female adult mouse cardiomyocytes are protected against oxidative stress.

Authors:  Fangfei Wang; Quan He; Ying Sun; Xiangguo Dai; Xiao-Ping Yang
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

Review 3.  ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.

Authors:  Yingmei Zhang; Jun Ren
Journal:  Pharmacol Ther       Date:  2011-06-12       Impact factor: 12.310

4.  Regional imbalanced activation of the calcineurin/BAD apoptotic pathway and the PI3K/Akt survival pathway after myocardial infarction.

Authors:  Tieluo Li; Ahmet Kilic; Xufeng Wei; Changfu Wu; Gary Schwartzbauer; G Kwame Yankey; Christopher DeFilippi; Meredith Bond; Zhongjun J Wu; Bartley P Griffith
Journal:  Int J Cardiol       Date:  2011-11-15       Impact factor: 4.164

5.  Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde.

Authors:  Heng Ma; Rui Guo; Lu Yu; Yingmei Zhang; Jun Ren
Journal:  Eur Heart J       Date:  2010-08-12       Impact factor: 29.983

6.  AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol.

Authors:  Wei Ge; Rui Guo; Jun Ren
Journal:  Free Radic Biol Med       Date:  2011-08-10       Impact factor: 7.376

Review 7.  Doxorubicin-induced chronic dilated cardiomyopathy-the apoptosis hypothesis revisited.

Authors:  Cynthia Kankeu; Kylie Clarke; Egle Passante; Heinrich J Huber
Journal:  J Mol Med (Berl)       Date:  2016-12-08       Impact factor: 4.599

8.  Local cooling provides muscle flaps protection from ischemia-reperfusion injury in the event of venous occlusion during the early reperfusion period.

Authors:  Ryan S Diederich; Arian Mowlavi; Garth Meldrum; Brad Medling; Reuben A Bueno; Michael W Neumeister
Journal:  Hand (N Y)       Date:  2008-09-24

9.  (-)-Epigallocatechin-gallate (EGCG) stabilize the mitochondrial enzymes and inhibits the apoptosis in cigarette smoke-induced myocardial dysfunction in rats.

Authors:  Gokulakrishnan Adikesavan; Magendira Mani Vinayagam; Liyakath Ali Abdulrahman; Thirunavukkarasu Chinnasamy
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

10.  SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70.

Authors:  Nagalingam R Sundaresan; Sadhana A Samant; Vinodkumar B Pillai; Senthilkumar B Rajamohan; Mahesh P Gupta
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.